trientine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vitaliti, A | 3 |
| Roccatani, I | 3 |
| Iorio, E | 3 |
| Perta, N | 3 |
| Gismondi, A | 3 |
| Chirico, M | 3 |
| Pisanu, ME | 3 |
| Di Marino, D | 3 |
| Canini, A | 3 |
| De Luca, A | 3 |
| Rossi, L | 3 |
1 other study available for trientine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe | 2023 |
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe | 2023 |
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe | 2023 |
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe | 2023 |